Buysse & Partners

Buysse & Partners Invest bvba is a private equity firm established in 2008 and headquartered in Antwerp, Belgium, with additional offices in Luxembourg City, Sao Paulo, and Guayaquil. The firm focuses on direct investments, particularly in management buy-outs, replacement and acceleration capital, and growth capital for small and medium-sized enterprises, primarily within the real estate sector. Buysse & Partners concentrates its investments in Europe, especially in Belgium, Luxembourg, and the Netherlands. In addition to direct investments, the firm engages in fund of fund investments in Latin America, targeting countries such as Brazil, Chile, Colombia, Peru, and Mexico. The firm typically seeks to invest between €5 million and €20 million per participation and prefers to pursue co-investment opportunities.

Peter De Bie

Partner

Julie de Bruyn

Investment Director

Johan Buyle

Partner

An Coenen

CFO - Controller

Evelien Coppens

Senior Investment Associate

Philip Corthout

Investment Manager

Sven Haest

Investment Manager

Epco Van Hemelen

Investment Associate

Dimitri Herbosch

Partner

Edgar Hujoel

Partner

Cedric Liekens

Partner

Nick De Luyck

Investment Manager

Guy Mertens

Partner

Florian Rotsaert

Investment Associate

Michiel Ruysschaert

Investment Associate

Loïc Vancauwenberghe

Senior Investment Associate

Alexander Vos

Investment Associate

Laurens Willems

Senior Investment Manager

6 past transactions

Moonbird

Venture Round in 2021
Moonbird BV, established in 2019 and located in Keerbergen, Belgium, specializes in developing biofeedback tools aimed at enhancing meditation and breathing exercises. The company offers a handheld device designed to assist users in relaxation and sleep by expanding and contracting in sync with their breathing rhythm. Equipped with a PPG sensor, the device is complemented by a mobile application that generates weekly reports, helping users monitor their progress. This innovative approach enables individuals to reduce anxiety, alleviate stress, and attain a state of calmness through personalized breathing exercises.

Twikit

Series A in 2019
Twikit NV operates a software platform that facilitates the transformation of products from digital inputs to configurable formats suitable for visual customization and digital manufacturing. Founded in 2012 and headquartered in Antwerp, Belgium, with additional offices in New York City and Stuttgart, the company specializes in mass customization and integrates various aspects of product parametrization, 3D visualization, and production output. Twikit's platform enables clients to achieve advanced product individualization through a seamless end-to-end solution, allowing real-time product visualization and 3D configuration. By combining expertise in software development, product design, and digital manufacturing, Twikit enhances the customization capabilities of brands and enterprises, streamlining their production processes and allowing for on-demand manufacturing.

BlueBee

Series A in 2016
Bluebee Holding B.V., based in Rijswijk, the Netherlands, develops a cloud-based genomics analysis platform that accelerates the processing of sequencing data. Founded in 2011, the company provides solutions for research centers, sequencing service providers, clinical labs, and kit providers, enabling them to manage, process, and share large volumes of genomic data efficiently and affordably. The platform is designed to address the challenges posed by the rapid advancements in next-generation DNA sequencing technology, offering high-performance computing and clinical-grade security. By facilitating faster data processing and deep analytics, Bluebee aims to enhance the implementation of whole genome diagnostics in clinical settings, ultimately supporting the development of personalized treatments and innovative healthcare solutions. As of June 2020, Bluebee operates as a subsidiary of Illumina, Inc.

Twikit

Seed Round in 2015
Twikit NV operates a software platform that facilitates the transformation of products from digital inputs to configurable formats suitable for visual customization and digital manufacturing. Founded in 2012 and headquartered in Antwerp, Belgium, with additional offices in New York City and Stuttgart, the company specializes in mass customization and integrates various aspects of product parametrization, 3D visualization, and production output. Twikit's platform enables clients to achieve advanced product individualization through a seamless end-to-end solution, allowing real-time product visualization and 3D configuration. By combining expertise in software development, product design, and digital manufacturing, Twikit enhances the customization capabilities of brands and enterprises, streamlining their production processes and allowing for on-demand manufacturing.

Ancoa Software

Series A in 2015
Ancoa Software Ltd. is a financial software company based in London, United Kingdom, specializing in contextual surveillance and analytics solutions for exchanges, regulators, and buy- and sell-side firms. Founded in 2010, Ancoa's monitoring platform enables clients to manage regulatory, reputational, and operational risks across various markets and asset classes, enhancing market integrity through improved visibility of trading behaviors. The company's suite of products includes AlertView for investigating abnormal trading alerts, MarketView for real-time monitoring of trading activities, TradeView for interactive visualization of trading data, and OrderView for reconstructing order books. Additionally, ReportView offers comprehensive reporting capabilities, DataView enables access to underlying market data, NetworkView provides insights into market participant behavior, and AnalyticsView allows users to interact with alerts and conduct historical data analysis. As of May 2017, Ancoa operates as a subsidiary of Cinnober Financial Technology AB.

BlueBee

Seed Round in 2015
Bluebee Holding B.V., based in Rijswijk, the Netherlands, develops a cloud-based genomics analysis platform that accelerates the processing of sequencing data. Founded in 2011, the company provides solutions for research centers, sequencing service providers, clinical labs, and kit providers, enabling them to manage, process, and share large volumes of genomic data efficiently and affordably. The platform is designed to address the challenges posed by the rapid advancements in next-generation DNA sequencing technology, offering high-performance computing and clinical-grade security. By facilitating faster data processing and deep analytics, Bluebee aims to enhance the implementation of whole genome diagnostics in clinical settings, ultimately supporting the development of personalized treatments and innovative healthcare solutions. As of June 2020, Bluebee operates as a subsidiary of Illumina, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.